Market Place
Sourcing Support
Janssen Biotech Tremfya (Guselkumab ) Receives Supplemental Approval In US
06 Apr 2019 //
FDA
US FDA approves Darzalex in combo with pomalidomide & dexamethasone for patients
19 Jun 2017 //
PHARMABIZ
Pulmatrix Licenses Novel Drug Candidates from RespiVert subsidiary of Janssen
13 Jun 2017 //
PR NEWSWIRE
J&J, Celltrion Remicade Biosimilar Dispute Could Settle, Analyst Says
08 Mar 2017 //
BNA
Ionis Pharma receives $5M milestone payment from Janssen under GI collaboration
28 Dec 2016 //
PHARMABIZ
Janssen Submits Two Applications To FDA Seeking Approval Of Simponi aria
20 Dec 2016 //
PR NEWSWIRE
J&J Appeals Remicade Patent Ruling as Pfizer Readies Biosimilar
02 Nov 2016 //
BLOOMBERG
FDA grants priority review for Genmabs’ daratumumab
12 Oct 2016 //
EUROPEAN PHARMACEUTICAL
U.S. FDA Grants Priority Review for Daratumumab in Relapsed Multiple Myeloma
07 Oct 2016 //
GLOBENEWEWIRE
Janssen seeks to expand use of multiple myeloma drug
20 Aug 2016 //
PHARMATIMES
Bristol-Myers` Opdivo front-and-center in yet another cancer-fighting team-up
27 Jul 2016 //
FIERCE PHARMA
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb
26 Jul 2016 //
PR NEWSWIRE
The Newly Launched IL-17 Inhibitor Cosentyx is Gradually Gaining Momentum in EU5
01 Jun 2016 //
PR NEWSWIRE
Janssen’s Stelara impresses in Crohn’s maintenance trial
25 May 2016 //
PHARMATIMES
MorphoSys takes Genmab, J&J to court over CD38 antibody patent
07 Apr 2016 //
FIERCE BIOTECH
J&J grabs prostate cancer rights for Tesaro`s niraparib in $500M deal
07 Apr 2016 //
FIERCE BIOTECH
FDA Approves IMBRUVICA for First-line Treatment of Chronic Lymphocytic Leukemia
05 Mar 2016 //
PR NEWS WIRE
UbiVac Opts to Stay in Portland, Oregon, Expands Lab Space By Factor of 10
18 Feb 2016 //
BIOSPACE
Empliciti on track for European approval in multiple myeloma
03 Feb 2016 //
PM LIVE
Janssen starts phase 2/3 trial of imetelstat in myelodysplastic syndromes
14 Jan 2016 //
PBR
GSK/Janssen RA drug on track for filing next year
17 Dec 2015 //
PHARMATIMES
First Data Unveiled from CALLISTO Program Examining the Use of XARELTO®
07 Dec 2015 //
PR NEWS WIRE
IMBRUVICA Ph2 RESONATE17 Data Show Robust Clinical Activity & Promising Outcomes
07 Dec 2015 //
PR NEWS WIRE
Real-World Data Confirms Safety and Efficacy Profile of XARELTO®
07 Dec 2015 //
PR NEWS WIRE
Janssen`s STELARA® in US and the EU for the treatment of Crohn`s disease
01 Dec 2015 //
PR NEWS WIRE
FDA approves Darzalex for patients with previously treated multiple myeloma
17 Nov 2015 //
FDA
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
14 Nov 2015 //
PR NEWS WIRE
Halozyme Announce Clinical Dosing Of Janssen`s Daratumuma by ENHANZE Technology
04 Nov 2015 //
PR NEWS WIRE
UbiVac Announces Collaboration with Johnson & Johnson…
29 Sep 2015 //
PR NEWS WIRE
J&J signs up to assess Nextera`s tech platform in rheumatoid arthritis
24 Sep 2015 //
FIERCE BIOTECH
Berkeley’s Aduro Biotech Isn’t Just on the Mark
21 Sep 2015 //
BIOSPACE
